| 注册
首页|期刊导航|世界中医药|基于中医传承辅助平台的中医药治疗乙肝肝硬化用药规律分析

基于中医传承辅助平台的中医药治疗乙肝肝硬化用药规律分析

张向磊 卢立伟 刘阳 魏小雪 李勇

世界中医药2016,Vol.11Issue(10):2160-2163,4.
世界中医药2016,Vol.11Issue(10):2160-2163,4.DOI:10.3969/j.issn.1673-7202.2016.10.060

基于中医传承辅助平台的中医药治疗乙肝肝硬化用药规律分析

Analysis on Medicinal Combination Rule for Liver Cirrhosis due to Chronic Hepatitis B by Traditional Chinese Medicine Inheritance Platform System

张向磊 1卢立伟 1刘阳 1魏小雪 1李勇2

作者信息

  • 1. 山东中医药大学第一临床医学院,济南,250355
  • 2. 山东省中医院肝病科,济南,250011
  • 折叠

摘要

Abstract

Objective: To explain the combination rules of medicinal for liver cirrhosis due to chronic hepatitis B collected in CNKI by traditional Chinese medicine ( TCM) inheritance Platform System .Methods: The prescriptions used for liver cirrhosis due to chronic hepatitis B in CNKI were collected and input into the TCM inheritance Platform System .TCM inheritance Platform System was used to explore the combination rules of medicinal in prescriptions for liver cirrhosis resulting from chronic hepatitis B . Results:The combination rules of medicinal were extracted based on the analysis of 253 cases of prescriptions by TCM inheritance Platform System.The frequent-used herbs were analyzed .Twenty-eight main combinations and 14 new prescriptions were extrac-ted.Conclusion:The complex combination rules of medicinal in prescriptions for liver cirrhosis due to chronic hepatitis B collect -ed in CNKI have been clarified by TCM inheritance Platform System , which is helpful to study the treatment of Chinese TCM for liver cirrhosis due to chronic hepatitis B .

关键词

中医传承辅助平台/乙肝肝硬化/用药规律

Key words

TCM Inheritance Platform System/Liver cirrhosis due to chronic hepatitis B/Combination rules of medicinals

分类

医药卫生

引用本文复制引用

张向磊,卢立伟,刘阳,魏小雪,李勇..基于中医传承辅助平台的中医药治疗乙肝肝硬化用药规律分析[J].世界中医药,2016,11(10):2160-2163,4.

基金项目

国家中医临床研究基地业务建设科研专项(编号:JDZX2012065) (编号:JDZX2012065)

山东省自然科学基金项目(编号:ZR2015PH055) (编号:ZR2015PH055)

山东省青少年教育科学规划课题大学生学术课题(编号:16BSH048) (编号:16BSH048)

世界中医药

OACHSSCDCSTPCD

1673-7202

访问量0
|
下载量0
段落导航相关论文